Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Background: Chinese patent medicine Tongxinluo capsule (TXL) is commonly used for cardio-cerebrovascular diseases. Previous research had demonstrated that TXL exhibited great clinical effects on the treatment of acute myocardial infarction (AMI), however there is a lack of systematic review. The pur...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Front Pharmacol
Главные авторы: Li, Min, Li, Chengyu, Chen, Shiqi, Sun, Yang, Hu, Jiayuan, Zhao, Chen, Qiu, Ruijin, Zhang, Xiaoyu, Zhang, Qin, Tian, Guihua, Shang, Hongcai
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2018
Предметы:
Pharmacology
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6085586/
https://ncbi.nlm.nih.gov/pubmed/30123126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.00830
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы